Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 621
Filtrar
1.
Vet. zootec ; 31: 1-20, 2024. ilus, tab
Artigo em Português | LILACS, VETINDEX | ID: biblio-1552920

RESUMO

As doenças respiratórias são consideradas doenças graves e potencialmente deletérias. Dentre elas, a asma e a bronquite crônica caracterizam-se como disfunções respiratórias que ameaçam constantemente o bem-estar dos gatos. Os pacientes apresentam mudanças na estrutura respiratória, reversíveis ou não, devido ao extenso quadro inflamatório, que obstrui o fluxo de ar, permite o acúmulo de muco e reduz o lúmen das vias aéreas. Os gatos acometidos apresentam tosses, respiração ruidosa, dispneia, e, em muitos casos, assumem posição ortopneica. O diagnóstico pode ser obtido através de exames de rotina, uso de radiografias torácicas, coleta e análise de fluidos broncoalveolares, e testes alergênicos. O manejo terapêutico baseia-se, combinado ou não, no uso de drogas como broncodilatadores, antiinflamatórios esteroidais, mucolíticos, antibióticos, agentes inalatórios e mudanças ambientais com objetivo de redução da exposição aos possíveis agentes alergênicos responsáveis pela incitação do quadro respiratório.


Respiratory diseases are considered serious and potentially harmful diseases. Among them, asthma and chronic bronchitis are characterized as respiratory disorders that constantly threaten the well-being of cats. The patients present changes in the respiratory structure, reversible or not, due to the extensive inflammatory condition, which obstructs the air flow, allows the accumulation of mucus and reduces the lumen of the airways. Affected cats have coughs, wheezing, dyspnoea, and in many cases assume an orthopneic position. The diagnosis can be obtained through routine exams, use of chest x-rays, collection and analysis of bronchoalveolar fluids, and allergen testing. Therapeutic management is based, combined or not, on the use of drugs such as bronchodilators, steroidal anti-inflammatory, mucolytics, antibiotics, inhalational agents and environmental changes in order to reduce exposure to possible allergenic agents responsible for the incitation of the respiratory condition.


Las enfermedades respiratorias son consideradas enfermedades graves y potencialmente dañinas. Entre ellos, el asma y la bronquitis crónica se caracterizan por ser trastornos respiratorios que amenazan constantemente el bienestar de los gatos. Los pacientes presentan cambios en la estructura respiratoria, reversibles o no debido al cuadro inflamatorio extenso, que obstruye el flujo de aire, permite la acumulación de moco y reduce la luz de las vías respiratorias. Los gatos afectados presentan tos, respiración ruidosa, disnea y, en muchos casos, adoptan una posición ortopneica. El diagnóstico se puede obtener mediante exámenes de rutina, uso de radiografías de tórax, recolección y análisis de líquidos broncoalveolares, y pruebas de alérgenos. El manejo terapéutico se basa, combinado o no, en el uso de fármacos como broncodilatadores, antiinflamatorios esteroides, mucolíticos, antibióticos, agentes inhalatorios y cambios ambientales con el objetivo de reducir la exposición a posibles agentes alergénicos responsables de incitar la afección respiratoria.


Assuntos
Animais , Gatos , Asma/patologia , Bronquite/patologia , Broncodilatadores/uso terapêutico , Obstrução das Vias Respiratórias/veterinária , Anti-Inflamatórios/uso terapêutico
2.
Chinese Journal of Contemporary Pediatrics ; (12): 626-632, 2023.
Artigo em Chinês | WPRIM | ID: wpr-982004

RESUMO

OBJECTIVES@#To study the clinical characteristics of plastic bronchitis (PB) in children and investigate the the risk factors for recurrence of PB.@*METHODS@#This was a retrospective analysis of medical data of children with PB who were hospitalized in Children's Hospital of Chongqing Medical University from January 2012 to July 2022. The children were divided into a single occurrence of PB group and a recurrent PB group and the risk factors for recurrence of PB were analyzed.@*RESULTS@#A total of 107 children with PB were included, including 61 males (57.0%) and 46 females (43.0%), with a median age of 5.0 years, and 78 cases (72.9%) were over 3 years old. All the children had cough, 96 children (89.7%) had fever, with high fever in 90 children. Seventy-three children (68.2%) had shortness of breath, and 64 children (59.8%) had respiratory failure. Sixty-six children (61.7%) had atelectasis and 52 children (48.6%) had pleural effusion. Forty-seven children (43.9%) had Mycoplasma pneumoniae infection, 28 children (26.2%) had adenovirus infection, and 17 children (15.9%) had influenza virus infection. Seventy-one children (66.4%) had a single occurrence of PB, and 36 cases (33.6%) had recurrent occurrence of PB (≥2 times). Multivariate logistic regression analysis showed that involvement of ≥2 lung lobes (OR=3.376) under bronchoscopy, continued need for invasive ventilation after initial removal of plastic casts (OR=3.275), and concomitant multi-organ dysfunction outside the lungs (OR=2.906) were independent risk factors for recurrent occurrence of PB (P<0.05).@*CONCLUSIONS@#Children with pneumonia accompanied by persistent high fever, shortness of breath, respiratory failure, atelectasis or pleural effusion should be highly suspected with PB. Involvement of ≥2 lung lobes under bronchoscopy, continued need for invasive ventilation after initial removal of plastic casts, and concomitant multi-organ dysfunction outside the lungs may be risk factors for recurrent occurrence of PB.


Assuntos
Feminino , Masculino , Criança , Humanos , Pré-Escolar , Insuficiência de Múltiplos Órgãos , Estudos Retrospectivos , Bronquite/etiologia , Dispneia , Derrame Pleural , Atelectasia Pulmonar , Plásticos , Insuficiência Respiratória
3.
Chinese Journal of Contemporary Pediatrics ; (12): 1107-1112, 2023.
Artigo em Chinês | WPRIM | ID: wpr-1009855

RESUMO

OBJECTIVES@#To study the efficacy and safety of Xiyanping injection through intramuscular injection for the treatment of acute bronchitis in children.@*METHODS@#A prospective study was conducted from December 2021 to October 2022, including 78 children with acute bronchitis from three hospitals using a multicenter, randomized, parallel-controlled design. The participants were divided into a test group (conventional treatment plus Xiyanping injection; n=36) and a control group (conventional treatment alone; n=37) in a 1:1 ratio. Xiyanping injection was administered at a dose of 0.3 mL/(kg·d) (total daily dose ≤8 mL), twice daily via intramuscular injection, with a treatment duration of ≤4 days and a follow-up period of 7 days. The treatment efficacy and safety were compared between the two groups.@*RESULTS@#The total effective rate on the 3rd day after treatment in the test group was significantly higher than that in the control group (P<0.05), while there was no significant difference in the total effective rate on the 5th day between the two groups (P>0.05). The rates of fever relief, cough relief, and lung rale relief in the test group on the 3rd day after treatment were higher than those in the control group (P<0.05). The cough relief rate on the 5th day after treatment in the test group was higher than that in the control group (P<0.05), while there was no significant difference in the fever relief rate and lung rale relief rate between the two groups (P>0.05). The cough relief time, daily cough relief time, and nocturnal cough relief time in the test group were significantly shorter than those in the control group (P<0.05), while there were no significant differences in the fever duration and lung rale relief time between the two groups (P>0.05). There was no significant difference in the incidence of adverse events between the two groups (P>0.05).@*CONCLUSIONS@#The overall efficacy of combined routine treatment with intramuscular injection of Xiyanping injection in the treatment of acute bronchitis in children is superior to that of routine treatment alone, without an increase in the incidence of adverse reactions.


Assuntos
Humanos , Criança , Injeções Intramusculares , Tosse/tratamento farmacológico , Estudos Prospectivos , Sons Respiratórios , Bronquite/tratamento farmacológico , Resultado do Tratamento
4.
Rev. Ciênc. Méd. Biol. (Impr.) ; 20(4): 601-609, fev 11, 2022. tab
Artigo em Português | LILACS | ID: biblio-1359371

RESUMO

Introdução: doenças crônicas como asma brônquica, alergias respiratórias ou doenças agudas recorrentes, como gripes, frequentemente acometem as crianças. Tais condições exigem o uso de medicamentos, normalmente sob a forma de xaropes, que podem se apresentar como genéricos ou de referência. A alta concentração em sacarose e o baixo pH dessas formulações, assim como o uso noturno e a falta de higienização após sua administração, são alguns fatores que podem contribuir para o potencial cariogênico e erosivo desses medicamentos. Objetivo: o objetivo deste estudo foi avaliar in vitro o potencial cariogênico e erosivo de xaropes infantis, de referência e genéricos, a partir de suas propriedades físico-químicas e identificar seus principais componentes a partir da análise de bulas e rótulos. Metodologia: foram analisados oito medicamentos de referência e os oito genéricos equivalentes, os quais foram avaliados quanto ao pH, a acidez titulável, a presença de sólidos solúveis totais (ºBrix) e a composição em sacarose e conservantes através da análise de bulas e rótulos. Resultados: constatou-se que 75% da amostra apresentou pH abaixo do crítico para desmineralização do esmalte dentário. A presença da sacarose e do ácido cítrico foi observada em 43,75% dos medicamentos, especialmente entre aqueles com altos valores de titulação. Conclusão: a maioria dos medicamentos apresentou pH abaixo do pH crítico para dissolução do esmalte dentário, havendo uma ampla variação da acidez titulável. As bulas dos medicamentos não informavam quanto ao risco de erosão dentária e de cárie, apesar da presença de sacarose em algumas formulações.


Introduction: chronic illnesses such as bronchial asthma, respiratory allergies or recurrent acute illnesses, such as the flu, often affect children. Such conditions require the use of medications, usually in the form of syrups, which can be presented as generic or reference ones. The high concentration of sucrose and the low pH of these formulations, as well as the night use and the lack of hygiene after its administration, are some factors that can contribute to the cariogenic and erosive potential of these drugs. Objective: the aim of this study was to evaluate in vitro the cariogenic and erosive potential of infant reference and generic syrups, based on their physical and chemical properties and to identify their main components from the analysis of package inserts and labels. Methodology: eight reference drugs and eight generic equivalents were analyzed, which were evaluated for pH, titratable acidity, the presence of total soluble solids (ºBrix) and the composition in sucrose and preservatives through the analysis of package inserts and labels. Results: it was found that 75% of the sample had a pH below the critical level for tooth enamel demineralization. The presence of sucrose and citric acid was observed in 43.75% of the drugs, especially among those with high titration values. Conclusion: most drugs had pH below the critical pH for tooth enamel dissolution, with a wide range of titratable acidity between them. The package inserts of the medications did not inform about the risk of dental erosion and caries, despite the presence of sucrose in some formulations.


Assuntos
Humanos , Criança , Asma , Erosão Dentária , Bronquite , Preparações Farmacêuticas , Doença Crônica , Cárie Dentária
5.
Journal of Southern Medical University ; (12): 747-751, 2022.
Artigo em Chinês | WPRIM | ID: wpr-936372

RESUMO

OBJECTIVE@#To explore the correlation of temperament type and mother's emotional state with acute respiratory tract infections in children so as to provide evidence for comprehensive treatment of the infections.@*METHODS@#A total of 200 children aged between 3 and 6 were enrolled in this study from two kindergartens of Guangzhou and Hengyang. The mothers were invited to complete a questionnaire of the children's general information followed by assessment using children's temperament scale and the Depression-Anxiety-Stress Scale.@*RESULTS@#The total incidence of acute respiratory infection was significantly higher in children with a hard- to-raise temperament than the easy- to-raise children (P < 0.05); the incidences of acute rhinitis, acute pharyngitis, acute laryngitis and acute bronchitis were all significantly higher in the hard-to-raise children (P < 0.05). A significant positive correlation was identified between the total number of episodes of acute respiratory tract infection in children and their mothers' stress and anxiety levels (P < 0.01). Acute rhinitis and acute tracheitis in the children were both positively correlated with the mothers' stress scores (P < 0.05), while acute pharyngitis and acute laryngitis were positively correlated with the mothers' anxiety scores (P < 0.05), while acute bronchitis was positively correlated with the mothers' stress and anxiety scores (P < 0.05). Multiple linear regression analysis with the factors influencing the types of acute respiratory tract infections in children as the independent variables suggested that the easy-to-raise type of temperament was a protective factor against acute rhinitis in children (P < 0.05), while mothers' anxiety was a risk factor of acute laryngitis in children (P < 0.05); the mothers' stress was a risk factor for acute bronchitis in children (P < 0.05).@*CONCLUSION@#Acute respiratory tract infection in children is closely related to the temperament type of the children and the emotional state of the mothers, which are important therapeutic targets in comprehensive interventions of acute respiratory tract infection in children.


Assuntos
Criança , Pré-Escolar , Feminino , Humanos , Bronquite , Laringite , Mães/psicologia , Faringite , Rinite , Temperamento
6.
Cambios rev. méd ; 20(2): 39-45, 30 Diciembre 2021. tabs.
Artigo em Espanhol | LILACS | ID: biblio-1368273

RESUMO

INTRODUCCIÓN. Existe relación entre la exposición de contaminantes en el aire y problemas respiratorios que van desde síntomas leves en vías respiratorias altas hasta enfermedades que pueden comprometer la vida de los pacientes como: neumonía, enfermedad pulmonar obstructiva crónica y cáncer pulmonar. OBJETIVO. Registrar los síntomas respiratorios presentados por agentes civiles de tránsito expuestos a smog. MATERIALES Y MÉTODOS. Estudio analítico transversal. Población de 3 458 y muestra de 454 participantes entre agentes civiles de tránsito, fiscalizadores de tránsito y personal administrativo de la Agencia Metropolitana de Tránsito en el año 2021, seleccionados por muestreo aleatorio simple estratificado para los dos grupos de participantes; se aplicó un sondeo digital basado en las encuestas: European Community Respiratory Health Survey y condiciones de trabajo. Para el análisis de datos se utilizó la herramienta EPI INFO, donde se realizó pruebas estadísticas bivariadas de Chi2 y análisis multivariado como regresiones logísticas crudas y ajustadas. RESULTADOS. Se observó que la población de trabajadores operativos en vía tuvo alrededor de dos veces más riesgo de desarrollar sibilancias en comparación a la población administrativa OR=2,1 (IC 95% 1,01­4,39); el personal operativo tuvo más del doble de riesgo de desarrollar bronquitis crónica versus la población administrativa OR=2,5 (IC 95% 1,14­5,73). Los resultados fueron ajustados mediante regresión logística con variables de condiciones de trabajo y salud (p=<0,05). CONCLUSIÓN. Se registró una relación significativa entre la contaminación ambiental por smog y enfermedades respiratorias a largo plazo.


INTRODUCTION. There is a relationship between exposure to air pollutants and respiratory problems ranging from mild upper respiratory symptoms to life-threatening diseases such as pneumonia, chronic obstructive pulmonary disease and lung cancer is evident. OBJECTIVE. To record the respiratory symptoms presented by civilian traffic officers exposed to smog. MATERIALS AND METHODS. Cross-sectional analytical study. Population of 3 458 and sample of 454 participants among civilian traffic agents, traffic inspectors and administrative personnel of the Metropolitan Traffic Agency in the year 2021, selected by simple stratified random sampling for the two groups of participants; a digital survey was applied based on the European Community Respiratory Health Survey and working conditions. For data analysis, the EPI INFO tool was used, where bivariate Chi2 statistical tests and multivariate analysis such as crude and adjusted logistic regressions were performed. RESULTS. It was observed that the population of operational track workers had about twice the risk of developing wheezing compared to the administrative population OR=2,1 (95% CI 1,01-4,39); operational personnel had more than twice the risk of developing chronic bronchitis versus the administrative population OR=2,5 (95% CI 1,14­5,73). Results were adjusted by logist regression with working conditions and health variables (p=<0,05). CONCLUSION. There was a significant relationship between smog pollution and long-term respiratory diseases.


Assuntos
Humanos , Masculino , Feminino , Adulto , Adulto Jovem , Doenças Respiratórias , Emissões de Veículos/toxicidade , Polícia , Poluição do Ar , Poluição Ambiental , Poluição Relacionada com o Tráfego , Bronquite , Doença Pulmonar Obstrutiva Crônica , Ar , Poluentes Atmosféricos , Efeitos da Contaminação do Ar , Asma Ocupacional , Doenças Profissionais
7.
Acta pediátr. hondu ; 12(1): 1237-1240, abr.-sep. 2021. ilus
Artigo em Espanhol | LILACS, BIMENA | ID: biblio-1381266

RESUMO

En los ámbitos científico e institucional existe controversia sobre el manejo idóneo de la bron- quiolitis en pacientes pediátricos. El objetivo de este trabajo es valorar el nivel de evidencia cientí- fica que existe sobre el manejo de la bronquiolitis para determinar si las recomendaciones actuales son o no adecuadas. Se realizó una revisión sis- temática de artículos científicos consultando di- versas bases de datos, sin restricción de fecha, en los idiomas español e inglés. Se incluyó literatura gris mediante búsqueda manual. No se hicieron restricciones respecto al tipo de estudio. Se re- visaron los resúmenes y en los casos necesarios los artículos completos, teniéndose en cuenta fi- nalmente todos los artículos que incluían apor- tes sobre el manejo adecuado de la bronquiolitis. Como resultado la mayoría de las recomenda- ciones realizadas por las sociedades fueron a tra- vés de guías de práctica clínica o artículos de opinión, concluyendo que no se cuenta con un esquema de tratamiento adecuado para tratar la bronquiolitis aguda, existiendo un manejo erróneo con el uso de esteroides y antibióticos, mientras que uno de los tratamiento más viables y costo efectivos queda en el olvido como es la solución hipertónica al 3%, la cual ha demostra- do reducción de la estancia hospitalaria...(AU)


Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Criança , Adolescente , Bronquite/diagnóstico , Broncodilatadores , Esteroides , Nebulizadores e Vaporizadores , Soluções Hipertônicas
8.
Acta pediátr. hondu ; 12(1): 1222-1230, abr.-sep. 2021. graf., tab.
Artigo em Espanhol | LILACS, BIMENA | ID: biblio-1372395

RESUMO

Antecedentes: La bronquiolitis es una enfermedad viral aguda del tracto respiratorio inferior en niños menores de dos años, con una tasa máxima de aparición entre 2-10 meses de edad. Objetivo: Evaluar eficacia y seguridad de solución salina hipertónica nebulizada con o sin epinefrina en el manejo de la bronquiolitis aguda. Materiales y métodos:Estudio cuasi-experimental longitudinal, en lactantes ingresados en Hospital Nacional Mario Catarino Rivas (HNMCR), con bronquiolitis aguda leve. Se analizaron 26 casos, asignados al azar, 12 recibieron nebulizaciones con solución salina hipertónica al 3% mas 1 ml de epinefrina (SSH+E) y 14 recibieron 3 ml de solución hipertónica al 3% (SSH), administrados cada 4 horas, y se realizaron análisis de la Escala de Wood Downes- Ferres, saturación de oxígeno y complicaciones posteriores a las nebulizaciones cada 6 horas, por un periodo de 24 horas. El estudio fue aprobado por un comité de ética. Resultados: La estancia hospitalaria se redujo significativamente en el grupo de SSH en comparación con el grupo SSH+E (1,79±0,80 días: 2,50±0,79 días, P = 0,032). El score clínico disminuyo en ambos grupos, pero no hubo diferencia estadísticamente significativa (p=0,187 vs p=0,074, al llegar y luego de 24 horas) Las complicaciones encontradas fueron estadísticamente significativas para el grupo de SSH+E, posterior a las primeras 3 nebulizaciones P = 0,007 y a las 12 horas P = 0,019. Conclusión: Las nebulizaciones con SSH y con SSH+E son igualmente eficaces, sin embargo, la SSH demostró mayor seguridad y acortó significativamente la estancia hospitalaria de los lactantes hospitalizados con bronquiolitis aguda leve...(AU)


Assuntos
Humanos , Masculino , Feminino , Lactente , Pré-Escolar , Solução Salina Hipertônica/uso terapêutico , Bronquite/diagnóstico , Infecções Respiratórias/complicações
9.
Acta otorrinolaringol. cir. cuello (En línea) ; 49(2): 112-120, 2021. TAB, ILUS, GRAF
Artigo em Espanhol | LILACS | ID: biblio-1253865

RESUMO

Resumen Introducción: actualmente los profesionales de la salud se enfrentan al manejo de las vías aéreas artificiales en grupos pediátricos, esto requiere de cuidados delicados y mucha atención para detectar, establecer y manejar situaciones apremiantes; por esta razón, existe un mayor riesgo de aparición de infecciones bacterianas traqueopulmonares. El objetivo del estudio fue analizar la caracterización de las infecciones en pacientes pediátricos portadores de cánula de traqueotomía en las diferentes publicaciones científicas. Materiales y métodos: se realizó una revisión sistemática mediante la búsqueda de la literatura existente entre los años 2015-2020 en las bases de datos Elsevier, PubMed, Google Académico y SciELO, teniendo en cuenta los criterios de inclusión artículos en idioma inglés, español y población de edad entre los 0-15 años con infección de cánula de traqueotomía en los años 2015-2020. Resultados: de 258 artículos distribuidos en las bases de datos, se seleccionaron 21 artículos que cumplían con los criterios de inclusión. Conclusiones: a pesar de que en la actualidad existan criterios clínicos, factores de riesgo y pruebas de laboratorio asociados a infecciones de la cánula postraqueotomía en pacientes pediátricos, se requiere mayor investigación para definir las guías clínicas de manejo en la toma de decisiones médicas. Asimismo, se consideró como limitación importante la cantidad de literatura existente con respecto al tema.


Abstract Introduction: Currently, health professionals face the management of artificial airways in pediatric groups, this requires delicate care and a lot of attention to detect, establish and manage pressing situations, which is why there is a greater risk of tracheo-pulmonary bacterial infections. The objective was to analyze the characterization of infections in pediatric patients with tracheostomy tubes in the different scientific publications. Method: A systematic review of the literature was carried out between the years 2015-2020 in Elsevier, PubMed, Google Academic and SciELO databases, taking into account the inclusion criteria of the population aged 0-15 years in the years 2015-2020. The amount of existing literature on the subject was considered an important limitation. Results: From 258 articles distributed in the databases, 21 articles were selected that met the inclusion criteria. Conclusions: Although there are currently clinical criteria, risk factors and laboratory tests associated with infections of the post-tracheotomy tube in pediatric patients, further research is required to define clinical guidelines for management in medical decision-making.


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Criança , Adolescente , Infecções Bacterianas/etiologia , Traqueíte/microbiologia , Traqueotomia/efeitos adversos , Bronquite/microbiologia , Cânula/efeitos adversos , Respiração Artificial/efeitos adversos , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/tratamento farmacológico , Traqueíte/diagnóstico , Traqueíte/tratamento farmacológico , Bronquite/diagnóstico , Bronquite/tratamento farmacológico
10.
Rev. am. med. respir ; 20(3): 270-272, sept. 2020. ilus
Artigo em Espanhol | LILACS, BINACIS | ID: biblio-1123091

RESUMO

Paciente de 88 años que consultó por presentar tos productiva con expectoración mucopurulenta de 15 días de evolución. Equivalentes febriles. No refirió pérdida de peso ni inapetencia. Al examen clínico, cicatriz de toracotomía en el hemitórax izquierdo. A la auscultación, hipoventilación generalizada en ambas playas pulmonares, con rales subcrepitantes húmedos en base derecha. La Rx. de Tórax solicitada reveló en la playa pulmonar derecha, retracción lobular superior y en la playa izquierda, múltiples imágenes circulares y geométricas, que ocupaban campos pulmonares superior y medio. Signo de la columna vertebral desnuda por retracción de la imagen cardiovascular hacia dicho hemitórax en el campo inferior


Assuntos
Humanos , Bronquite , Exame Físico , Tórax
11.
ARS med. (Santiago, En línea) ; 45(3): 16-21, sept. 30, 2020.
Artigo em Espanhol | LILACS | ID: biblio-1255280

RESUMO

Introducción: las unidades aerodigestivas proveen un cuidado complejo coordinado a pacientes pediátricos con condiciones congé-nitas o adquiridas de grados variables que afectan la vía respiratoria, el tracto gastrointestinal, la deglución y el crecimiento. La primera unidad aerodigestiva de Guatemala fue fundada en el año 2018 en un hospital privado, y por ser la única de su tipo en el país, no se tenían datos locales al respecto. Pacientes y métodos: se llevó a cabo un estudio retrospectivo cuantitativo; se analizó el total de casos reportados en la unidad aerodigestiva pediátrica desde el 1 de enero de 2018 hasta el 31 de mayo de 2019, se contó con un total de 69 casos. Resultados: el 79% de los pacientes presentaron más de una patología de diferente etiología. La indicación principal para realizar la triple endoscopia fue tos crónica. Los diagnósticos encontrados como comorbilidades con mayor frecuencia fueron bronquitis bacteriana recurrente y enfermedad por reflujo gastroesofágico. Conclusión: la triple endoscopia es útil tanto en el diagnóstico como en la toma de decisiones en el manejo de las patologías aerodigestivas pediátricas de alta complejidad. Es una herramienta útil que pone en evidencia que múltiples etiologías pueden contribuir a síntomas crónicos de la vía aérea, y que estas pueden pasarse por alto si se realiza un solo procedimiento.


Introduction: Aerodigestive programs provide coordinated interdisciplinary care to pediatric patients with complex congenital or ac-quired conditions affecting breathing, the gastrointestinal tract, swallowing, and growth. The first aerodigestive program in Guatemala was founded in the year 2018 in a private hospital and, since it's one of its kind in the country, there was no local data reported. Patients and methods: A total of 69 cases of children who were evaluated at the aerodigestive program from January 1st, 2018 to May 31st, 2019, were retrospectively analyzed in a quantitative study. Results:79% of patients presented more than one pathology from different etio-logy. Overall the main indication for the triple scope was chronic cough. The findings reported that recurrent bacterial bronchitis and gastroesophageal reflux were the most common comorbidities present in the same patient. Conclusion:The triple scope procedure is a useful investigative tool for patients with recalcitrant aero-digestive complaints. In particular, the triple scope can yield more than one specialty-specific diagnosis normally missed by one procedure.


Assuntos
Humanos , Pacientes , Pediatria , Estudos Retrospectivos , Estudos de Avaliação como Assunto , Guatemala , Bronquite , Broncoscopia , Refluxo Gastroesofágico , Comorbidade , Deglutição , Trato Gastrointestinal , Endoscopia , Crescimento , Laringoscopia
12.
Medicina (B.Aires) ; 80(4): 397-400, ago. 2020. graf
Artigo em Espanhol | LILACS | ID: biblio-1154836

RESUMO

Resumen La traqueobronquitis aspergilar es una forma poco frecuente de aspergilosis invasiva reportada excepcionalmente en el paciente inmunocompetente. Su diagnóstico es difícil, y los tratamientos propuestos hasta ahora son de escasa efectividad, todo lo cual constituye un verdadero problema para el equipo de salud. Presentamos el caso de una paciente de 28 años, inmunocompetente y sin antecedentes epidemiológicos, que desarrolló traqueobronquitis necrotizante por aspergilosis invasiva y recibió tratamiento con voriconazol con instilación local por broncoscopia con buena respuesta.


Abstract Aspergillus tracheobronchitis is a rare form of invasive aspergillosis reported exceptionally in the immunocompetent patient. Its diagnosis is difficult, and the treatments proposed so far are of little effectiveness, all of which constitute a real problem for the health team. We present the case of an immunocompetent 28 yearsold woman, with no epidemiological background, who developed necrotizing tracheobronchitis due to invasive aspergillosis and received voriconazole with local instillation by bronchoscopy with a good response.


Assuntos
Humanos , Feminino , Adulto , Aspergilose , Infecções Respiratórias , Traqueíte , Bronquite , Broncoscopia , Antifúngicos
13.
Philippine Journal of Otolaryngology Head and Neck Surgery ; : 78-79, 2020.
Artigo em Inglês | WPRIM | ID: wpr-961080
15.
Chinese Journal of Contemporary Pediatrics ; (12): 429-434, 2020.
Artigo em Chinês | WPRIM | ID: wpr-828727

RESUMO

OBJECTIVE@#To study the clinical features of severe type 7 adenovirus pneumonia in children.@*METHODS@#A retrospective analysis was performed for the clinical data of children who were diagnosed with severe type 7 adenovirus pneumonia from February to June, 2019.@*RESULTS@#Among the 45 children, the male/female ratio was 3:2 and the median age was 14 months. All children had repeated fever, cough, and pulmonary moist rales, and the mean duration of fever was 14±4 days. The median time from fever to dyspnea was 8 days, and the time from fever to mechanical ventilation was 11.6±2.5 d. There was no significant increase in white blood cell count, with neutrophils as the main type. There were slight reductions in hemoglobin and albumin, while platelet and fibrinogen remained normal. There were increases in aspartate aminotransferase, lactate dehydrogenase, procalcitonin, and C-reaction protein. The detection rate of mixed pathogens was 84%. Effusion in both lungs was the major change on chest imaging (64%). Bronchoscopic manifestations were endobronchitis, tracheomalacia, and plastic bronchitis. The incidence rate of respiratory complications was 100%, and extrapulmonary complications mainly involved the circulatory system (47%), digestive system (36%), and nervous system (31%). Among the 45 children, 16 were administered with 400 mg/kg intravenous immunoglobulin (IVIG) daily for 5 days, with a mean duration of fever of 16±5 days, and 29 were administered with 1 g/kg IVIG daily for 2 days, with a mean duration of fever of 13±4 days; there was a significant difference in the mean duration of fever between the two groups (P=0.046). The overall mortality rate was 11%.@*CONCLUSIONS@#Severe type 7 adenovirus pneumonia in children has severe conditions, with a high incidence rate of complications and a high mortality rate, so it should be diagnosed and treated as early as possible.


Assuntos
Feminino , Humanos , Lactente , Masculino , Adenoviridae , Bronquite , Febre , Pneumonia Viral , Estudos Retrospectivos
16.
Rev. bras. ter. intensiva ; 31(4): 541-547, out.-dez. 2019. tab
Artigo em Português | LILACS | ID: biblio-1058050

RESUMO

RESUMO As infecções do trato respiratório inferior associadas à ventilação mecânica são uma das complicações mais frequentes em pacientes em ventilação mecânica. Há muitos anos, a traqueobronquite associada à ventilação mecânica tem sido considerada uma doença que não demanda antibioticoterapia. Na última década, diversos estudos demonstraram que a traqueobronquite associada à ventilação mecânica deve ser considerada um processo intermediário que leva à pneumonia associada à ventilação mecânica, uma vez que apesar de ter impacto limitado sobre a mortalidade dos pacientes gravemente enfermos internados nas unidades de terapia intensiva, em contrapartida, demonstra associação significativa com o aumento dos custos hospitalares desses pacientes, assim como do tempo de internação na unidade de terapia intensiva e hospitalar, do uso de antibióticos, e da duração da ventilação mecânica. Embora ainda necessitemos de evidências científicas mais robustas, especialmente no que tange às modalidades terapêuticas, os dados atuais a respeito da traqueobronquite associada à ventilação mecânica salientam que há desfechos suficientemente importantes que exigem vigilância epidemiológica e controle clínico adequados.


ABSTRACT Ventilator-associated lower respiratory tract infection is one of the most frequent complications in mechanically ventilated patients. Ventilator-associated tracheobronchitis has been considered a disease that does not warrant antibiotic treatment by the medical community for many years. In the last decade, several studies have shown that tracheobronchitis could be considered an intermediate process that leads to ventilator-associated pneumonia. Furthermore, ventilator-associated tracheobronchitis has a limited impact on overall mortality but shows a significant association with increased patient costs, length of stay, antibiotic use, and duration of mechanical ventilation. Although we still need clear evidence, especially concerning treatment modalities, the present study on ventilator-associated tracheobronchitis highlights that there are important impacts of including this condition in clinical management and epidemiological and infection surveillance.


Assuntos
Humanos , Respiração Artificial/efeitos adversos , Traqueíte/etiologia , Bronquite/etiologia , Respiração Artificial/métodos , Infecções Respiratórias/etiologia , Infecções Respiratórias/epidemiologia , Traqueíte/epidemiologia , Bronquite/epidemiologia , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Antibacterianos/administração & dosagem
17.
Rev. medica electron ; 41(2): 445-453, mar.-abr. 2019.
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1004280

RESUMO

RESUMEN La tos crónica en los adultos puede ser causada por muchas causas, existen cuatro principales: el síndrome de tos de la vía aérea superior, enfermedad por reflujo gastroesofágico, reflujo laringofaríngeo, asma bronquial, y bronquitis eosinofílica no asmática. Todos los pacientes deben evaluarse clínicamente con espirometria, y comenzar con tratamiento empírico. Otras causas potenciales incluyen el uso de inhibidores de la enzima convertidora de la angiotensina, cambios medioambientales, uso del tabaco, enfermedad pulmonar obstructiva crónica, y la apnea obstructiva del sueño. La radiografía del tórax puede orientar hacia causas infecciosas, inflamatorias, y malignas. Los pacientes con tos crónica refractaria pueden remitirse a la consulta especializada de un neumólogo u otorrinolaringólogo, además de un ensayo terapéutico con gabapentin, pregabalin, y psicoterapia.


ABSTRACT Although chronic cough in adults can be caused by many etiologies, four conditions account for most cases: upper airway cough syndrome, gastro-esophageal reflux disease, also known as laryngo- pharyngeal reflux disease, bronchial asthma, and non-asthmatic eosinophilic bronchitis. All patients should be evaluated clinically with spirometry, and empiric treatment should be initiated. Other potential causes include angiotensin-converting enzyme inhibitor use, environmental triggers, tobacco use, chronic obstructive pulmonary disease, and obstructive sleep apnea. Chest radiography can rule out concerning infectious, inflammatory, and malignant thoracic conditions. Patients with refractory chronic cough should be referred to a pulmonologist or otolaryngologist in addition to a therapeutic trial of gabapentin, pregabalin, and psychotherapy.


Assuntos
Humanos , Adulto , Doença Crônica/epidemiologia , Medicina Baseada em Evidências , Tosse/diagnóstico , Tosse/etiologia , Tosse/psicologia , Tosse/tratamento farmacológico , Tosse/terapia , Tosse/epidemiologia , Asma/diagnóstico , Bronquite/diagnóstico , Refluxo Gastroesofágico/diagnóstico , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Pregabalina/uso terapêutico , Gabapentina/uso terapêutico
18.
Ciênc. cuid. saúde ; 18(2): e45611, 2019-03-18.
Artigo em Português | LILACS | ID: biblio-1121490

RESUMO

Objective:to identify rates of hospitalizations fromchronic diseases among children under the age of five from 2010 to 2015. Method:Ecological study using a time series trend. Data were collected from the Hospital Information System of the Brazilian Public Health System between January and March 2016. After data were digitalized, descriptive analysis was performed using EpiInfo. Results:The frequency of hospitalizations caused by chronic diseases among children younger than 5 years old remained between 10.8% and 11.2% in Brazil and 13.8% to 16.1% in Rio Grande do Sul. Respiratory disorders were the most prevalent, both in the state of Rio Grande do Sul and at the national level. Asthma was themost prevalent reason for hospitalization. Final considerations:Even though, in general, the causes of hospitalizations tend to remain stable, emphasis is placed on the high prevalence of chronic conditions in childhood and their impact on the lives of children and their families.


Objetivo:identificar as taxas de hospitalização por doenças crônicas em crianças menores de cinco anos de 2010 a 2015. Método:estudo ecológico de tendência de série temporal. Os dados foram extraídos do Sistema de Informações Hospitalares do Sistema Único de Saúde e coletados entre janeiro e março de 2016. Após digitalização dos dados, foi realizada a análise descritiva, utilizando programa EpiInfo. Resultados:a frequência de hospitalizações por doenças crônicas em crianças menores de cinco anos vem se mantendo constante entre 10,8% a 11,2% no Brasil e 13,8% a 16,1% no Rio Grande do Sul. Identificou-se que os distúrbios respiratórios foram os mais prevalentes nos dois cenários, dando destaque à asma(como o motivo de internação mais prevalente. Considerações finais:apesar de as causas de internações apresentarem, de modo geral, uma tendência à estabilidade, dá-se ênfase à alta prevalência da agudização das condições crônicas na infância e à repercussão delaspara a vida da criança e sua família.


Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Pré-Escolar , Brasil , Criança , Doença Crônica , Hospitalização , Asma , Terapêutica , Sistema Único de Saúde , Bronquite , Família , Saúde da Criança , Prevalência , Atenção à Saúde , Menores de Idade , Epilepsia , Prevenção de Doenças , Promoção da Saúde , Hospitais
19.
China Journal of Chinese Materia Medica ; (24): 5294-5302, 2019.
Artigo em Chinês | WPRIM | ID: wpr-1008398

RESUMO

To systematically review the effectiveness and safety of Reduning Injection in the treatment of acute tracheal-bronchitis.Four Chinese databases( CNKI,VIP,Wan Fang,Sino Med) and three English databases( Cochrane Library,Medline,Web of Science) were systematically and comprehensively retrieved. The retrieval time was from the establishment of each database to April 2019.Randomized controlled trials( RCTs) for the treatment of acute tracheal-bronchitis with Reduning Injection were collected. Two researchers independently conducted literature screening,data extraction and risk assessment for bias. Rev Man 5.3 software was used for data analysis. Fourteen studies were included,and the total sample size was 1 652 at last. Meta-analysis results show that in the aspect of total clinical effective rate,Reduning Injection was superior to ribavirin( RR = 1. 37,95%CI[1. 28,1. 47],P<0. 000 01); Reduning Injection combined with conventional therapy was better than conventional therapy alone( RR = 1. 14,95% CI[1. 09,1. 19],P <0. 000 01); Reduning Injection combined with azithromycin was better than azithromycin therapy alone( RR = 1. 21,95% CI[1. 07,1. 37],P = 0. 002). In the aspect of clinical symptoms,the time in average fever disappearance of Reduning Injection therapy was shorter than that of ribavirin therapy( MD =-1.68,95%CI[-1. 72,-1. 49],P<0. 000 01); the time in cough disappearance of Reduning Injection therapy was shorter than that of ribavirin therapy( MD =-2. 57,95%CI[-2. 91,-2. 24],P<0. 000 01); the time in lung rales disappearance,Reduning Injection therapy was superior to ribavirin therapy( MD =-2. 26,95% CI[-2. 71,-1. 80],P<0. 000 01),and Reduning Injection combined with conventional therapy was superior to conventional therapy( MD =-1. 77,95% CI[-1. 95,-1. 59],P<0. 000 01). Based on the findings,Reduning Injection can improve the total effective rate,reduce the average time of disappearance in fever,cough and lung rales,with mild adverse reactions and a low incidence. However,the quality of the literatures included is not high,it is necessary to adopt large-sample-size,rigorously designed clinical trial protocols in line with the international standards,in a bid to improve the quality of evidence.


Assuntos
Humanos , Azitromicina/uso terapêutico , Bronquite/tratamento farmacológico , Quimioterapia Combinada , Medicamentos de Ervas Chinesas/uso terapêutico , Injeções
20.
China Journal of Chinese Materia Medica ; (24): 4387-4396, 2019.
Artigo em Chinês | WPRIM | ID: wpr-1008204

RESUMO

To evaluate the effectiveness and safety of Xiyanping Injection in the treatment of acute bronchitis in children. The research systematically retrieved four Chinese databases( namely CNKI,VIP,Wan Fang,Sino Med) and four English databases( namely EMbase,Cochrane Library,Medline,Clinical Trail.gov). The retrieval time ranged from the commencement of each database to April2019. According to pre-set inclusion criteria and exclusion criteria,randomized controlled trials( RCTs) of Xiyanping Injection in the treatment of acute bronchitis in children were screened out. The quality assessment of the included studies was performed using the " Cochrane Bias Risk Assessment" tool,and the Meta-quantitatively analysis on the included studies was performed using Rev Man 5.3 software. A total of 648 articles were retrieved,and 10 studies were finally included. Except for one multi-arm test,the total sample size was 1 260,including 630 cases in the test group and 630 cases in the control group. The overall quality of the included study was not high. The results of Meta-analysis showed that in terms of antipyretic time,Xiyanping Injection combined with routine therapy was superior to routine therapy in the shortening of fever time in children with acute bronchitis( MD =-0.94,95%CI[-1.18,-0.70],P<0.000 01); in the overall efficacy,Xiyanping Injection combined with routine therapy was superior to routine therapy( RR = 1. 34,95% CI[1.26,1.42],P<0.000 01) and Yanhuning Injection + routine therapy( RR = 1.28,95%CI[1.19,1.38],P<0.000 01); descriptive analysis showed that Xiyanping Injection was excellent in the overall efficacy in treating acute bronchitis in children. The differences between the two groups were statistically significant( P< 0.000 1). The adverse reactions included in the study were mild adverse reactions,with no impact on treatment. Based on the results of this study,Xiyanping Injection combined with routine therapy or other Western medicine had a certain effect on acute bronchitis in children,especially in improving the overall efficacy of acute bronchitis in children. No serious adverse reactions were observed. And in the time of fever,cough and cough disappearance time,lung voice loss time,Xiyanping Injection + routine therapy or Western medicine therapy was better than routine therapy or Western medicine therapy. However,the small size of included studies,the low quality of the included studies,and the existence of publication bias and the low quality of the evidence had impacts on the reliability of the conclusion. Therefore,more large-sample,multi-center,well-designed,rigorous randomized controlled trials with best case reports are required to further verify the efficacy and safety.


Assuntos
Criança , Humanos , Masculino , Doença Aguda , Bronquite/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Injeções , Reprodutibilidade dos Testes
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA